A multidisciplinary clinical observational
program advancing real-world HNSCC
management across the patient journey
June 12–13, 2026 | Semmelweis University ENT Clinic | Budapest
“Redefining HNSCC: from treatment to integrated care” is a two-day, practice-focused Clinical Observational Program hosted at Semmelweis University ENT Clinic in Budapest. Bringing together multidisciplinary experts to translate advances in HNSCC into real-world care, and delivered in partnership with MSD Hungary, the program combines clinic immersion, tumor boards, and interactive sessions to strengthen decision-making, integrate patient pathways, and enable immediate application in daily practice.
Location
Semmelweis University ENT Clinic
1083 Budapest, Szigony u. 36., Hungary
Date
June 12–13, 2026
Please complete the registration form below to confirm your participation.
Registration deadline: May 20, 2026
"*" indicates required fields
12:00–12:30 Arrivals & lunch
12:30–12:40
Welcome and objectives | Béla Merkely (Rector), László Tamás, Kornél Dános
12:40–13:10
Imaging: contemporary head and neck imaging (CT, MRI, PET-CT) | Dávid Tárnoki, Gergely Kiss
13:10–13:40
Cytology and Histopathology: sampling, diagnostic algorithms, pathology reporting | Judit Halász
13:40–13:55 Coffee break
13:55–14:25
Prehabilitation: perioperative optimization, nutrition, physiotherapy, smoking cessation | Fruzsina Bódis
14:25–15:05
Double Tumor Board: pre-treatment and post-treatment “What next?” decision support | Kornél Dános, Imre Uri, Benedek Besenczi, Orsolya Zámbó, Angéla Horváth
15:05–15:50
Operation planning – organ preservation vs. non-preservation; indications for preoperative immunotherapy | Kornél Dános, Gábor Répássy
15:50–16:40
Orbit and skull base surgery: complex resections and reconstructions | Tibor Szalóki, Gábor Forgács
16:40–16:55 Coffee break
16:55–17:35
Radiotherapy and chemoradiotherapy; integration with reconstructive surgery | Zoltán Takácsi-Nagy
17:35–18:20
Chemo- and immunotherapy: role of the Central Pharmacy, protocols, medication safety | Péter Vajda, Péter Prekopp
18:20 Adjourn
20:00 Group dinner
09:00–09:40
HPV-associated tumors: epidemiology, biology, treatment specifics | Kornél Dános
09:40–10:40
Re-irradiation and/or salvage surgery: indications, risks, outcomes |
Zoltán Takácsi Nagy/Péter Prekopp, Orsolya Zámbó, Gábor Répássy
10:40–11:00 Coffee break
11:00–11:40
Head and neck cancer patient education: fejnyakibetegut.hu and practical tools | Kornél Dános, László Tamás
11:40–12:30
Recurrent/residual disease: retreatment strategies | Péter Prekopp, Orsolya Zámbó
12:30–13:15 Lunch
13:15 –14:30
Interactive Tumor Board: multidisciplinary case discussion (MDT) | Kornél Dános,
Imre Uri, Benedek Besenczi, Orsolya Zámbó, Angéla Horváth
14:30–15:00
Closing discussion and next steps | László Tamás, Kornél Dános, MSD
15:00 Adjourn